Serious adverse events and coping strategies of CAR-T cells in the treatment of malignant tumors

Chimeric antigen receptor T (CAR-T) cells technology has been successfully used in the treatment of B cell-derived hematological tumors and multiple myeloma. CAR-T cells are also being studied in a variety of solid tumors. Current clinical reports on CAR-T cells in the treatment of malignant tumors...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiujin, Li, Peng, Tian, Bin, Kang, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772271/
https://www.ncbi.nlm.nih.gov/pubmed/36569917
http://dx.doi.org/10.3389/fimmu.2022.1079181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772271/
https://www.ncbi.nlm.nih.gov/pubmed/36569917
http://dx.doi.org/10.3389/fimmu.2022.1079181

Ejemplares similares